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Objective: Magnetic resonance-guided focused ultrasound surgery (MRgFUS)
lesioning is a new treatment for brain disorders. However, the skull is a major barrier
of ultrasound sonication in MRgFUS because it has an irregular surface and varies
its size and shape among individuals. We recently developed the concept of skull
density ratio (SDR) to select candidates for MRgFUS from among patients with essential
tremor (ET). However, SDR is not the only factor contributing to successful MRgFUS
lesioning treatment—refining the target through exact measurement of the ultrasonic
echo in the transducer also improves treatment efficacy. In the present study, we carried
out MRgFUS lesioning using an autofocusing echo imaging technique. We aimed to
evaluate the safety and efficacy of this new approach, especially in patients with low
SDR in whom previous focusing methods have failed.
Methods: From December 2019 to March 2020, we recruited 10 patients with ET or
Parkinson’s disease (PD) who had a low SDR. Two patients dropped out of the trial due
to the screening failure of other medical diseases. In total, eight patients were included:
six with ET who underwent MRgFUS thalamotomy and two with PD who underwent
MRgFUS pallidotomy. The autofocusing echo imaging technique was used in all cases.
Results: The mean SDR of the patients with ET was 0.34 (range: 0.29–0.39), while
that of the patients with PD was 0.41 (range: 0.38–0.44). The mean skull volume of
patients with ET was 280.57 cm3 (range: 227–319 cm3), while that of the patients with
PD was 287.13 cm3 (range: 271–303 cm3). During MRgFUS, a mean of 15 sonications
were performed, among which a mean of 5.63 used the autofocusing technique. The
mean maximal temperature (Tmax) achieved was 55.88◦C (range: 52–59◦C), while the
mean energy delivered was 34.75 kJ (range: 20–42 kJ) among all patients. No serious
adverse events occurred during or after treatment. Tmax or sonication factors (skull
volume, SDR, sonication number, autofocusing score, similarity score, energy range,
and power) were not correlated with autofocusing technique (p > 0.05, autofocusing
score showed a p-value of 0.071).
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Conclusion: Using autofocusing echo imaging lesioning, a safe and efficient MRgFUS
treatment, is available even for patients with a low SDR. Therefore, the indications
for MRgFUS lesioning could be expanded to include patients with ET who have an
SDR < 0.4 and those with PD who have an SDR < 0.45.
Clinical Trial Registration: clinicaltrials.gov, identifier: NCT03935581.
Keywords: essential tremor, Parkinson’s disease, auto-focusing, echo imaging, magnetic resonance-guided
focused ultrasound surgery
INTRODUCTION
Magnetic resonance-guided focused ultrasound surgery
(MRgFUS) through the human skull is a novel treatment
for functional brain disorders. It has been widely applied to treat
movement disorders such as essential tremor (ET; Chang et al.,
2015, 2016, 2019; Elias et al., 2016; Gallay et al., 2016; Chazen
et al., 2018; Jung et al., 2018; Wang et al., 2018; Gasca-Salas et al.,
2019) and Parkinson’s disease (PD; Na et al., 2015; Bond et al.,
2017; Weintraub and Elias, 2017; Martinez-Fernandez et al.,
2018), intractable neuropathic pain, and even neuropsychiatric
disorders such as obsessive–compulsive disorder (Jeanmonod
et al., 2012; Jung et al., 2015; Chang et al., 2016; Kim et al.,
2018). It is a relatively safe procedure with minimal side
effects and proven efficacy in various diseases (Na et al., 2015;
Bond et al., 2017; Chazen et al., 2018; Wang et al., 2018;
Gasca-Salas et al., 2019).
However, MRgFUS has some limits. The skull is barely
penetrable to ultrasound because bone has a high absorption of
ultrasonic energy. Therefore, in some patients, MRgFUS cannot
reach the therapeutic temperature of over 54◦C necessary for
ablative brain lesions (Wang et al., 2018; Chang et al., 2019;
D’Souza et al., 2019; Jung et al., 2019). To address this, we
developed the concept of skull density radio (SDR) as a factor
to predict such treatment failure (Chang et al., 2016). The SDR
reflects the uniformity of skull density, which heavily affects the
penetration properties of the skull. An SDR below 0.4 (low SDR)
is generally considered inadequate or inconducive to optimal
thermal lesioning in MRgFUS. Until recently, SDR was the only
factor known to influence maximum temperature (Tmax) with
relative low sonication energy (Chang et al., 2016, 2019; Wang
et al., 2018; Boutet et al., 2019; D’Souza et al., 2019; Jung et al.,
2019). However, other factors contributing to successful lesioning
in MRgFUS treatment have now been discovered (Chang et al.,
2016, 2019; Wang et al., 2018; Boutet et al., 2019; D’Souza et al.,
2019; Jung et al., 2019).
In addition, ultrasonic waves passing through the skull are
heavily distorted. Although the skull is round, it has an irregular
surface and varies in size and shape among individuals. As
a result, its focal point, global thickness, and SDR also vary.
Moreover, different therapeutic targets, such as the pallidum
and the more lateral thalamus, require different incident angles.
Therefore, focusing on different targets and modifying the
incident angle using the transducer can also affect treatment
outcomes (Jung et al., 2019). Hence, an effective focusing
technique is essential for treatment success.
The Insightec Exablate 4000 MRgFUS system uses a computed
tomography (CT)-based acoustic model of the patient’s skull as a
focusing guide. This model simulates ultrasound phase distortion
and correction in situ during clinical treatment. This approach
is successful in high-SDR skulls when the target is near the
geometrical center of the skull, such as in ET treatments in the
ventral intermediate nucleus (VIM; Chang et al., 2016). When the
target is located further from the skull center (typically≥ 20 mm)
and in the case of a low SDR, the likelihood of lesion induction
and treatment success drops significantly (Jung et al., 2019).
In the present clinical study, we performed MRgFUS using
the new autofocusing echo imaging technique—an Insightec-
developed method that uses acoustic signals from microbubbles
of ultrasound contrast agent administered intravenously and is
activated when the ultrasound focuses on the target area in
patients with ET or PD undergoing MRgFUS thalamotomy or
pallidotomy. We aimed to evaluate the safety and efficacy of
this new approach, especially in patients with low SDR in whom
previous focusing methods have failed.
METHODS
This study was a prospective, single-center, open label, and
clinical trial. Data from the autofocusing echo imaging technique
were collected at Yonsei University College of Medicine,
Severance Hospital from December 2019 to March 2020. We
recruited 10 patients, two of whom were excluded from the
trial because they had a history of other medical issues of
screening failure. In total, the study included eight patients: six
who underwent MRgFUS thalamotomy for ET and two who
were subjected to MRgFUS pallidotomy for PD. Each patient
provided informed consent, and the study was conducted with
the permission and under the supervision of the Severance
Hospital Institutional Review Board (Seoul, South Korea), and
the Korea Food and Drug Administration (Figure 1). The clinical
trial was registered at ClinicalTrials.gov (identifier number:
NCT03935581). Each patient underwent CT to evaluate their
SDR, which was calculated using the CT Density Analysis Tool
(InSightec). Skull volume was measured using three-dimensional
image software (Aquarius version 4.4; TeraRecon, Foster City,
CA, United States).
Autofocusing Echo Imaging Technique
The MRgFUS procedure was performed in a 3-T MRI scanner
(GE Medical Systems, Milwaukee, WI, United States) using the
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FIGURE 1 | CONSORT flow diagram of patients for the study.
Exablate 4000 device (InSightec), which has a 1,024-element
phase array transducer that incorporates an independent phase
and amplitude control for each element. The autofocusing
echo imaging technique was applied (Figure 2). The clinical
study was performed using the 650-kHz system, although the
autofocusing echo imaging technique itself is not limited to a
specific frequency.
Autofocusing echo imaging functions by introducing a point
scatterer in the focal region. This point scatterer reflects
ultrasound illumination in a spherical wave form, regardless of
the incident wave properties. This wave reflected from inside
the brain allows direct measurement of phase and amplitude
distortions that can be used to optimize phase correction and
relative amplitude calibration (Figure 2).
Like routine ultrasound imaging, to achieve imaging of
microbubble activity with low intensity ultrasound waves,
introduction of an Ultrasound Contrast Agent (USCA)
is required (Qin et al., 2009). The USCA micro bubbles
(DEFINITY R©), with well-known and controlled size and
concentration (0.08 µl/kg DEFINITY R© activated with Vialmix R©
machine), are injected into the patient’s blood stream in bolus
before the autofocusing echo imaging sequence is applied. Then,
through an injection of the DEFINITY along with a transmission
of a series of low-power, low-energy FUS pulses (The pulse
power range for AF imaging is 7–300 vs. 100–1,500 W during
actual treatment). The autofocusing echo imaging technique can
be applied and used to improve the focusing quality. At the end
of the autofocusing scan, the ExAblate Neuro Type 1.0 system
will automatically calculate the phase and amplitude corrections
necessary for the system to produce the sonication at the desired
location and volume. Following the AF echo imaging scans,
a T2∗/GRE MR sequence will be performed to evaluate any
possible signs of hemorrhage. In addition, a rapid MR sequence
will be performed to check for the presence of bleeding, edema, or
any other adverse radiologic effect. This will be a safety check. In
the event of new neurological deficits, other imaging modalities
(including CT) will be performed immediately in addition to
neurological and physical examination. The ExAblate system will
not allow treatment to proceed for at least 12 min from the time
of the last injection of DEFINITY to allow complete absorption
of the microbubbles. Ultrasound contrast agent microbubbles
are used as a reflector and are administrated into the blood
stream. Although these microbubbles provide a strong signal,
the emerging echo signal from the target region is still about
Frontiers in Neuroscience | www.frontiersin.org 3 January 2021 | Volume 14 | Article 592763
fnins-14-592763 January 11, 2021 Time: 11:42 # 4
Chang et al. Autofocusing Echo Imaging MRgFUS
FIGURE 2 | Upper: Ultrasound contrast agent microbubbles emit a spherical wave as a point scattering source. Aberration corrections are deduced directly from the
measurement. Lower: Typical recorded signal. Different colors represent different channels. Multiple reflections from the skull dominate the signal. The microbubble
signal is invisible at this scale.
60 dB weaker than reflections from the surrounding skull, which
strongly reflect the incident signal and heavily attenuate the
signals from the microbubbles. Time-of-flight separation does
not resolve this problem because there are multiple reflections,
and the irregular skull base is close to the ultrasound source
(Figure 2). Instead, because the microbubble signal has intrinsic
non-linearity and stochasticity, it can be differentiated from the
strong background signal by analyzing signal stability.
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For this reason, clinicians using this technique must
implement simultaneous measurements on all channels. In the
Exablate system, all power transmission channels are also used as
acquisition channels. The acquisition hardware is a proprietary
development of Insightec and consists of 32 acquisition
cards, each of which consists of 32 channels. Each card has
embedded computing and can be programmed independently
for acquisition and signal processing. The programming and
data exchange are performed through a local Ethernet network.
To enhance the signal-to-noise ratio and dynamic range, I/Q
demodulation was implemented in burst signals of ∼50 µs.
These bursts (trigger frames) are repeated with variable periods
of several microseconds each. The background and microbubble
response signals are separated based on a search for short-
lived stochastic events. An initial guess for phase correction
is preferable to produce local field maxima near the desired
target. No initial phase information or iterative approach is
necessary for this method. The calculations of the echo imaging
correction do not take into account the phase information
of the initial guess. The microbubble concentration should be
sufficiently low to allow time separation of single microbubble
detection events. The acoustic power level should be sufficient
to excite the microbubbles. Further increases in power lead to
additional stochastic signals from living tissue that degrade signal
quality. Pulse power is increased manually to ensure the patient’s
safety. The number of detected microbubble signals is reported
to the physician as a feedback about signal quality. Twenty
detected events are typically enough to allow effective correction.
Data collection stops automatically in the software at above 60
detected events. Ideally, each peak detected can be used to correct
aberrations. However, signals are mixed and should be checked
for validity. The algorithm models the signal as a spherical
waveform centered at an arbitrary point. Phase front distortion
is assumed to be the same for all point sources. Each candidate
waveform is checked for correlation with the others to establish
the data set to be used for aberration correction. The amount of
correlations between peaks detected is reported to the physician
as an “autofocusing score,” which is a value between 0.0 and
1.0 assigned to each acoustic correction table (ACT) produced
from successful autofocusing sonication. The autofocusing score
denotes the quality of the ACT. ACTs with an autofocusing
score below 0.50 are discarded. For a given spot, the ACT with
the highest score will be selected for use with the autofocusing
echo imaging method. In addition, the result is compared to
previously used corrections from echo imaging measurements
or CT-based modeling and reported as a “similarity score”
(0.0–1.0), which denotes the similarity between the newly
calculated ACT and the ACT currently in use. Similarity is
expected to be high (>0.8) between autofocusing ACTs. Lower
values may indicate unreliable measurement and that additional
autofocusing sonication should be performed. If there is no active
autofocusing ACT for the current active spot, a CT-based ACT is
used as a reference, although the similarity may be low. A given
autofocusing ACT is only valid at the active spot for which it
was calculated, allowing for location adjustments ≯5 mm and
ideally <3 mm. The score values represent peak intensity ratios
within the framework of the algorithm. The user must perform
at least two independent echo imaging measurements to ensure
that the results are consistent. Based on these measurements, the
physician decides whether the correction is usable. As established
by hydrophone scans (Figure 3) in a previous ex vivo study, echo
imaging correction is similar to hydrophone-based correction,
which is more sophisticated rather than CT-based scans. In
addition to phase distortion correction, relative transmission can
be extracted for each element in post-processing analysis. In
future software versions, this will be used for precise in situ
simulation of the focal spot shape.
Clinical Evaluation
For patients with ET, for evaluating tremor, a maximum upper
extremity clinical rating scale for tremor (CRST) sub-score of 32
points was calculated in the treated, tremor-dominant hand by
summing the observed and performance-based scores from Parts
A and B on the treated or contralateral side before and 1 month
after MRgFUS thalamotomy. In patients with PD, symptoms
were evaluated with the score of Part 3 of the unified PD rating
scale (UPDRS), which was measured before and 1 month after
MRgFUS pallidotomy.
Data and Statistics
Statistics were performed using SPSS 25 (IBM Corporation,
New York, NY, United States). Linear regression tests were
measured to measure the relevancy of various factors, while
Tmax measurement and the paired t-test were used to compare
clinical improvement after the procedure. All p-values < 0.05
were considered statistically significant.
RESULTS
In total, eight patients underwent MRgFUS lesioning using the
autofocusing echo imaging technique. Among these patients, six
had ET and two had PD. The six patients with ET underwent left
thalamotomy because all were right-handed and their baseline
mean CRST score in the dominant hand was 34 (range: 27–53).
The two patients with PD underwent left pallidotomy to control
levodopa-induced dyskinesia; their baseline mean UPDRS Part 3
score was 36 (34 and 38).
The mean SDR of the patients with ET was 0.34 (range: 0.29–
0.39), and the mean skull volume was 280.57 cm3. The mean SDR
of the patients with PD was 0.41 (range: 0.38–0.44), and the mean
skull volume was 287.13 cm3 (range: 271–303 cm3; Table 1).
During the MRgFUS, an average of 15 sonications were
performed, among which an average of 5.63 used the
autofocusing echo imaging technique. The autofocusing
echo imaging technique showed a higher similarity score, which
means a higher reliability. The average similarity score between
CT and AF was 0.58; in contrast, the average similarity score
between multiple autofocusing technique was 0.95. The mean
Tmax achieved was 55.88◦C (range: 52–59◦C). The mean energy
delivered was 34.75 kJ (range: 20–42 kJ; Table 2).
The mean post-MRgFUS lesioning CRST was 11 (range:
0–17), which was measured 1 month after the MRgFUS (Table 3).
The dominant hand CRST score differed significantly 1 month
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FIGURE 3 | Ex vivo hydrophone focal scans at the 30 mm off-center point in the skull. The left column shows computed tomography-based correction used as an
initial guess. The middle column represents microbubble-based correction, while the right column depicts a hydrophone-based result. The same acoustic power
was emitted for all scans. Relative peak intensity values can be used as focusing accuracy criteria. Algorithm similarity score: AF/CT = 0.55, AF/hydrophone = 0.85.
after MRgFUS (p = 0.002 by paired t-test), while the score
in the non-dominant hand did not (p = 0.530). In addition,
performance score (CRST Part C) differed significantly after
MRgFUS (p= 0.003). No serious adverse events occurred during
or after treatment. Among the sonication factors (skull volume,
SDR, sonication number, autofocusing score, similarity score,
energy range and power, and Tmax), none differed significantly
(p > 0.05), and the autofocusing score showed a p-value of
0.071 (Table 2).
After the MRgFUS lesioning, the UPDRS score showed
significant improvement. The mean UPDRS Part 3 score of
the two patients with PD was reduced from 36 to 24 (26 and
22), 1 month after the MRgFUS autofocusing echo imaging
pallidotomy. However, because of the small number of patients,
we could not measure statistical significance. No adverse effects
of microbubbles were observed in all eight patients. No serious
adverse events occurred during or after MRgFUS lesioning using
the autofocusing echo imaging technique.
DISCUSSION
Although MRgFUS is safe and efficient, the number of patients
indicated for the procedure is limited because the appropriate
treatment temperature cannot be reached in some patients.
Specifically, patients with a low SDR are typically excluded
from MRgFUS treatment (Chang et al., 2016, 2019; Jung et al.,
2019). We previously reported the importance of measuring
SDR and the clinical significance of SDR scores (Chang et al.,
2016, 2019; Jung et al., 2019). The SDR indicates the ratio of
Hounsfield unit value between the marrow and cortical bone
on the CT (Chang et al., 2016). A low SDR indicates that the
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TABLE 1 | The demography of patients with magnetic resonance guided focused








Mean SDR (total) 0.35
SDR (ET) 0.34
SDR (PD) 0.41
Mean volume (total) 282.21
Volume (ET) 280.57
Volume (PD) 287.13
Note. ET, essential tremor; PD, Parkinson’s disease; VIM, Ventral intermediate
nucleus; GPi: Globus pallidus interna; and SDR, skull density ratio.
cortical bone has a higher density than the trabecular bone
(Chang et al., 2016). When ultrasound waves pass through the
skull, they refract, reflect, and attenuate because of differences in
acoustic impedance.
In studies of SDR in the normal population, one third of
the people had an SDR below 0.4, which is generally considered
unfavorable for MRgFUS in ET. In patients with PD, the target
GPi is more lateral than the VIM, indicating a more diverse
incident angle. This is also an obstacle for MRgFUS, resulting in
significant energy loss, distortion of the penetrating ultrasound
beam, and unsuccessful lesioning (Jung et al., 2019). Thus, only
patients with an SDR above 0.45 are indicated for MRgFUS
pallidotomy to treat PD.
To treat targets in the brain through the intact skull, clinicians
must refocus the beam after it passes through the non-uniform,
non-spherical bony tissue of the skull. Focus correction predicts
skull-generated phase aberrations at each target point inside the
brain and corrects the phases of each transducer element to
compensate for it. Until now, focus correction was based on an
acoustic model derived from high-resolution pre-operative CT
TABLE 3 | Comparison of pre and post MRgFUS AF echo imaging thalamotomy
changes of CRST score for ET patients.
Patient Pre op Post op
Right Left Part C Right Left Part C
1 17 12 12 5 11 3
2 13 16 18 0 17 0
3 28 26 25 8 27 7
4 18 11 14 10 13 7
5 16 10 11 11 7 5
6 19 7 15 6 11 1
Mean 18.5 13.7 15.8 6.7 14.3 3.8
images of the skull. The autofocusing technique was developed
to overcome the ultrasound characteristics such as distortion and
reflections. The autofocusing echo imaging technique used in the
present study relies on accurate measurement of the ultrasound
echo by each of the 1,024 transducer elements. This data can then
be used to compute the phase delay per element. Autofocusing
echo imaging in the present study allowed more accurate
correction than previous CT-based correction (Figure 4).
In the present study, every patient successfully underwent
MRgFUS lesioning using the autofocusing echo imaging
technique without any side effects. None of the patients had
headache or nausea during the procedure. The target lesions were
made exactly in the planned area (VIM thalamus for patients with
ET and GPi for patients with PD), as confirmed by follow-up MRI
in all patients (Figure 5). Immediately after the sonication, the
patients’ clinical symptoms were subjectively improved, as were
the CRST score in patients with ET and the UPDRS score in
patients with PD.
Temperature was over 54◦C in all patients with ET. In those
with PD, the Tmax was over 52◦C. We could have raised the
Tmax to 54◦C in these patients by raising the energy, but the
targeted ablative lesion was confirmed by MRI, so no additional
sonication was carried out to avoid side effects. Since the GPi
is more lateral than the VIM and therefore requires a different
ultrasound incident angle, it was difficult to raise the temperature
TABLE 2 | Summary of outcomes of MRgFUS AF echo imaging technique.





















1 ET VIM, Left 291 0.37 15 33 58 9 75 0.57 0.89 0.89 Improved None
2 ET VIM, Left 227 0.39 16 20 59 4 25 0.63 0.99 0.85 Improved None
3 ET VIM, Left 290.97 0.36 12 35 57 3 20 0.68 0.99 0.91 Improved None
4 ET VIM, Left 319.24 0.31 12 39 55 5 25 0.61 0.97 0.87 Improved None
5 ET VIM, Left 299.23 0.29 19 42 56 4 27 0.7 0.96 0.81 Improved None
6 PD GPi, Left 271 0.38 13 40 52 9 85 0.34 0.97 0.79 Improved None
7 ET VIM, Left 256 0.33 16 37 57 4 30 0.68 0.89 0.88 Improved None
8 PD GPi, Left 303.26 0.44 17 32 53 7 70 0.43 0.95 0.81 Improved None
Average 282.21 0.36 15 34.75 55.88 5.63 44.63 0.58 0.95 0.85
Note. Dx, Diagnosis; ET, essential tremor; PD, Parkinson’s disease; VIM, Ventral intermediate nucleus; GPi, Globus pallidus interna; SDR, skull density ratio; AF, auto
focusing echo imaging; Tmax, Maximal temperature; and S/E, side effect.
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FIGURE 4 | Upper: In vivo phase correction compared in a clinical experiment. The left side shows computed tomography (CT)-based correction. The right side
represents the echo imaging method. The image is projected onto the transducer surface. Echo imaging correction is calculated independently of the CT-based
phases. Algorithm similarity score: AF/CT = 0.63. Lower: Transmission signal amplitudes (relative) measured in vivo using echo imaging. Image is projected onto the
transducer surface.
of the targeting lesion using the previous MRgFUS method.
However, using the autofocusing echo imaging technique, we
raised the target temperature enough for lesioning.
With the autofocusing echo imaging technique, patients with
ET who have an SDR below 0.4 and those with PD who
have an SDR below 0.45 could achieve the ideal therapeutic
temperature to create a permanent lesion, even though MRgFUS
was previously contraindicated in these patients.
Although the present study was conducted using a small
number of patients, it showed the efficacy of both MRgFUS
thalamotomy and pallidotomy using the autofocusing echo
imaging technique. Furthermore, it showed that this technique
can even be used in patients with an SDR below 0.4, unlike
previous methods.
Recently, various techniques to overcome SDR, skull volume,
and incident angle have been used in the clinical field to
overcome such barriers, such as increasing the sonication number
or sonication power. However, these techniques show adverse
effects, such as failure of thermal lesioning, necrosis in the skull
bone marrow, abnormal thermal shape of the target, or abnormal
cavitation signal in an unexpected lesion (Schwartz et al., 2018;
Wang et al., 2018).
Further research with larger populations and follow-ups is
required to confirm the efficacy and unexpected side effects of
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FIGURE 5 | Upper: Magnetic resonance (MR) images taken immediately after MR-guided focused ultrasound autofocusing echo imaging thalamotomy in a patient
with essential tremor. Lower: MR images taken immediately after MR-guided focused ultrasound autofocusing echo imaging pallidotomy in a patient with Parkinson’s
disease.
MRgFUS lesioning using autofocusing echo imaging. Using the
new autofocusing echo imaging technique, complications of the
previous MRgFUS lesioning would be reduced. Autofocusing
echo imaging has focusing ability similar to hydrophone-based
methods. It produces sharp and tight spots with higher peak
intensity and temperature. Clinicians must account for these new
parameters when applying the technique. For example, treatment
strategy based on the peak temperature will lead to smaller lesions
than previously.
CONCLUSION
Using the autofocusing echo imaging technique, MRgFUS
lesioning treatment is now safe and efficient in patients with low
SDR. As such, the technique could expand the indications for
MRgFUS lesioning to include patients with ET patients who have
an SDR of <0.4 and patients with PD who have an SDR < 0.45.
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